Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 2, Issue 4, Pages 278-288Publisher
NATURE RESEARCH
DOI: 10.1038/nrd1065
Keywords
-
Ask authors/readers for more resources
In the absence of effective vaccines to control herpesvirus infections, nucleosidic antiviral drugs have been the mainstay of clinical treatment since their development in the late 1970s. However, given the drawbacks of these drugs, including the increasing emergence of drug-resistant clinical isolates, new strategies for treating herpesvirus infections are warranted. A range of promising new drugs with novel molecular targets has been developed, but will they cure latent infections?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available